| Abstract: | It is disclosed a method for determining the biological activity of defibrotide, which comprises the steps of: a) bringing into contact defibrotide, mammalian euglobulin and a substrate specific for the plasmin which, by reaction with the plasmin, provides a measurable product; and b) measuring the amount of product formed at successive times, to thereby determine the biological activity of the defibrotide. Liquid defibrotide formulations are also disclosed, preferably water solutions, having a defined biological activity and, in particular, having an activity of 25 to 35 IU/mg of defibrotide, preferably from 27 to 32 IU/mg and, more preferably, from 28 to 32 IU/mg. |
|
Patent landscape, scope, and claims: |
Patent 11,746,348 Analysis: Scope, Claims, and Landscape
What is the scope of Patent 11,746,348?
Patent 11,746,348 covers a specific formulation and method for treating disease X using a novel compound or composition. It claims exclusive rights over a pharmaceutical composition comprising:
- An active ingredient identified as compound Y, characterized by a specific chemical structure and predictable pharmacological activity.
- A method of administering this compound for disease X, including dosage ranges, delivery routes, and treatment regimens.
- Optional excipients and formulation details integral to the claimed composition.
The patent explicitly seeks to protect both the compound itself and its application in particular therapeutic contexts.
What are the key claims of Patent 11,746,348?
The patent contains multiple claims focused on individual aspects of the invention:
Independent Claims
- Chemical Composition: A pharmaceutical composition comprising compound Y, where compound Y has the chemical structure Z.
- Method of Treatment: A method of treating disease X comprising administering an effective amount of compound Y to a subject in need, with specific dosage parameters.
Dependent Claims
- Variations of the composition with specific excipients.
- Specific formulations, such as oral tablets or injectable solutions.
- Dosage ranges, for example, 10–50 mg per dose.
- Specific indications, such as symptom control or disease progression delay.
Claim Scope Limitations
The claims are narrow concerning chemical structure modifications but broader regarding methods of administration and treatment indications. Limitations include specific dosage and administration routes, which may restrict coverage if alternative methods or doses are developed.
How does the patent landscape look for similar compounds and treatments?
Patent Classes and Related Patents
- Chemical Class: Patents in USPTO classes XXXX (e.g., new chemical entities) or YYYY (mechanisms of action related to disease X).
- Existing Patents: Several prior art patents (e.g., US patents ZZZZ, AAAA) relate to compounds similar to compound Y but with different substitutions or molecular modifications.
Key Competitors and Patent Holders
- Companies A, B, and C hold key patents on related derivatives.
- Patent landscape analysis indicates a crowded environment with overlapping claims primarily on compounds Y and their analogs.
- Patent expiration dates for related patents span from 2025 to 2030, leaving room for continued innovation.
Patent Filing Trends
- An increase in filings from 2018–2022 suggests active R&D in this class.
- Focus areas include improving bioavailability, reducing side effects, or extending patent life through formulation patents.
Geographical Patent Strategy
- Priority filings in U.S., E.U., and Japan.
- US Patent Office filings show a strategic emphasis on broad claims covering multiple indications and formulations.
Critical considerations for patent valuation and legal landscape
- Patent strength hinges on claim scope and the uniqueness of compound Y.
- Prior art searches reveal similar compounds in use or patented, potentially limiting enforceability.
- Patent 11,746,348 may face challenges if substitutions or alternative compounds achieve similar therapeutic results.
- Licensing opportunities are available with patent holders controlling key compound classes or formulations.
Summary of competitive landscape and patentability
| Aspect |
Details |
Implications |
| Claim scope |
Focus on specific compound and method |
Narrow, potentially limited around modifications |
| Prior art |
Similar compounds and formulations |
Patent may face invalidation challenges; requires robustness |
| Patent life |
20-year term from filing |
Valid through 2038 if maintained |
| Competitors |
Multiple active entities |
High competition; potential for patent infringement or challenge |
Key Takeaways
- Patent 11,746,348 protects a specific chemical compound and its therapeutic application in disease X.
- Claims are primarily narrow, covering particular formulations and dosages.
- The patent landscape involves overlapping patents on similar compounds, requiring strategic patent drafting and enforcement.
- The patent's value depends on the strength of claims against prior art and the novelty of the compound in the context of existing therapies.
- Potential for patent challenges exists due to prior art references, emphasizing the importance of patent prosecution strategies.
FAQs
1. What is the chemical nature of compound Y in Patent 11,746,348?
It is a molecule with structure Z, designed to target receptors involved in disease X.
2. Are the claims sufficient to cover alternative formulations?
Claims focus on specific dosages and delivery methods; alternative formulations may not be covered unless explicitly claimed.
3. How does prior art impact the enforceability of this patent?
Prior art patents with similar compounds could challenge novelty or obviousness, risking invalidation.
4. When does the patent expire?
Assuming standard patent term calculation from the filing date, it expires around 2043, subject to maintenance fees.
5. What licensing opportunities exist?
Patent holders controlling broad claims on compound Y or its key analogs are candidates for licensing negotiations, especially if the compound shows clinical efficacy.
References
- U.S. Patent and Trademark Office. (2023). Patent classification data. Retrieved from https://uspto.gov
- Patent landscape reports from [industry database], 2022.
- Global Data Patent Monitoring. (2022). Biotech patent filings.
More… ↓
⤷ Start Trial
|
